AI Summary
5 min readInside Oak HC/FT's $1M to $100M Check Strategy
Annie Lamont, founder and managing partner of Oak HC/FT, has spent over 40 years investing across healthcare, fintech, and technology. Her firm manages $14 billion, has produced 70-plus exits and 15 IPOs, and Lamont herself has been named the number-one healthcare investor on the Forbes Midas List seven times. In a conversation at the New York Stock Exchange, she laid out how the firm's strategy has evolved, where AI is having real impact, and why most companies claiming AI-driven valuations won't survive the correction.
The AI Inflection Point in Life Sciences
Oak HC/FT has been watching AI for a decade without seeing it produce developable therapeutics. That changed in the last two years. Lamont describes the shift as "the advent of LLMs with the infrastructure around them" combined with biological models that are not LLMs but are specific to chemistry and drug design. The firm's investment in Chai Discovery — a company building models for drug design and discovery — signals a deliberate push deeper into life sciences. Oak is adding partners in San Francisco and building out a San Francisco office because so much of the AI work in life sciences is happening there.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of Sourcery
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:00) **Opening & Background** - Host sets up Annie Lamont's legendary status: $14B managed, 70+ exits, 15 IPOs, #1 healthcare investor.
- 2 (02:03) **Oak HC/FT's Strategy & AI Evolution** - Lamont explains the firm's focus on horizontal platforms spanning healthcare and fintech.
- 3 (04:12) **AI's Explosion in Life Sciences** - Lamont describes the recent breakthrough in AI for drug design and discovery after a decade of limited progress.
- 4 (07:12) **The China Threat in Life Sciences** - Lamont warns of a growing competitive threat from China in pharmaceutical research.
- 5 (10:57) **Chai Discovery's Roadmap & Technical Approach** - Lamont details how AI is redesigning every step of drug design through simulation.
- 6 (13:08) **Timing & Defensibility: Devoted Health as a Case Study** - Lamont explains how Oak times its entry into AI categories and uses Devoted as a model for durable, defensible AI application.
- 7 (17:04) **When Will Legacy Institutions Take a Hit?** - Lamont discusses the slow but inevitable transformation of legacy healthcare systems.
+ Full timestamped outline available in the app
Show Notes
Annie Lamont is Co-Founder and Managing Partner of Oak HC/FT, the healthcare and fintech investment firm she built with Andrew Adams. Across 40+ years she has managed $14B, backed 70+ successful exits and 15 IPOs, and been named the top healthcare investor on the Forbes Midas List multiple times. Her portfolio includes athenahealth, Devoted Health, One Medical, CareBridge, VillageMD, Main Street Health, Komodo Health, and Chai Discovery.
Recorded at the New York Stock Exchange, the conversation covers China taking 50% of pharma's outside research dollars, clinical trial reform at the FDA, and Chai Discovery's roadmap from antibodies to peptides to small molecules. Lamont also explains how AI can cut the 25% to 30% of healthcare costs that are administrative.
On the investing side, she walks through backing repeat founders Todd Park and Brad Smith, CareBridge's acquisition by Elevance, Oak's $1M to $100M check sizes across a $2B fund, and newer portfolio companies Halluminate and Auger. The episode closes with the Brex Performance segment on mentors.
"I just think you've got 10% of the world that's worth it & 90% that's not."
We cover:
› Why AI drug discovery changed in the last 2 years
› China's rise in life sciences
› Devoted Health tripling in size and halving its operating ratio
› Why only 10% of AI companies justify their valuations
› Auger and Dave Clark's $100M AI supply chain build
Annie Lamont: https://x.com/annielamont
Molly O’Shea: https://x.com/MollySOShea
Sourcery: https://x.com/sourceryy
𝐄𝐏𝐈𝐒𝐎𝐃𝐄 𝐋𝐈𝐍𝐊
YouTube: https://youtu.be/sjd_G6-k930
𝐒𝐏𝐎𝐍𝐒𝐎𝐑𝐒
• Brex—The modern finance platform, combining the world’s smartest corporate card with integrated expense management, banking, bill pay, & travel. https://brex.com/sourcery
• Zone—develops next-generation data center campuses, partnering with AI companies, site developers and technology leaders to bring compute online faster and at scale. Visit: https://zonefrontier.com